Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary artery

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 1, 2010, Pages

  Ma, Huijuan ^a,b   He, Qiong ^a   Dou, Dou ^a   Zheng, Xiaoxu ^a   Ying, Lei ^a   Wu, Yuming ^b   Raj, J Usha ^c   Gao, Yuansheng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Guanosine 3 ,5 cyclic monophosphate dependent protein kinase; Myosin light chain phosphatase; Vasodilatation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC AMP; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOHEXIMIDE; LACTACYSTIN; MYOSIN LIGHT CHAIN PHOSPHATASE; MYOSIN PHOSPHATASE TARGET SUBUNIT 1; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL PIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PULMONARY ARTERY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CYCLIC GMP; ENZYME INHIBITORS; LUNG; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; PROTEIN ISOFORMS; PROTEIN PHOSPHATASE 1; PULMONARY ARTERY; QUINOXALINES; SWINE; TRIAZENES; VASOCONSTRICTOR AGENTS;

EID: 77953508462     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00340.2009     Document Type: Article

References (49)

1. Butt E, Pöhler D, Genieser HG, Huggins JP, Bucher B. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br J Pharmacol 116: 3110-3116, 1995. (Pubitemid 26008854)
2. Chen FC, Brozovich FV. Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure. J Vasc Res 45: 445-45, 2008.
3. Chen FC, Ogut O, Rhee AY, Hoit BD, Brozovich FV. Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. J Mol Cell Cardiol 41: 488-495, 2006. (Pubitemid 44344279)
4. Curry-McCoy TV, Osna NA, Donohue TM Jr. Modulation of lysozyme function and degradation after nitration with peroxynitrite. Biochim Biophys Acta 1790: 778-876, 2009.
5. Dou D, Ma H, Zheng X, Ying L, Guo Y, Yu X, Gao Y. Degradation of leucine zipper positive isoform of MYPT1 may contribute to development of nitrate tolerance. Cardiovasc Res 86:151-159, 2010.
6. Dou D, Zheng X, Qin X, Qi H, Liu L, Raj JU, Gao Y. Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries. Br J Pharmacol 153: 497-507, 2008. (Pubitemid 351199026)
7. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726-731, 1995.
8. Francis SH, Corbin JD. Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 56: 237-272, 1994. (Pubitemid 24111861)
9. Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide 21: 149-156, 2009.
10. Gao Y, Dhanakoti S, Tolsa JF, Raj JU. Role of protein kinase G in nitric oxide and cGMP-induced relaxation of newborn ovine pulmonary veins. J Appl Physiol 87: 993-998, 1999. (Pubitemid 29436975)
11. Gao Y, Dhanakoti S, Trevino EM, Wang X, Sander FC, Portuga AD, Raj JU. Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs. Am J Physiol Lung Cell Mol Physiol 286: L786-L792, 2004.
12. Gao Y, Zhou H, Raj JU. Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries in newborn lambs. Circ Res 76: 559-565, 1995.
13. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188, 1995.
14. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428, 2002. (Pubitemid 34654457)
15. Hartshorne DJ, Ito M, Erdödi F. Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem 279: 37211-37214, 2004. (Pubitemid 39195423)
16. 2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci 104: 109-115, 2007.
17. Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86: 1-23, 2006.
18. Huang QQ, Fisher SA, Brozovich FV. Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation. J Biol Chem 279: 597-603, 2004.
19. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1-21, 1989.
20. Jaikirshan JK, Katherine MJ, Frank VB, Steven AF. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001. (Pubitemid 33652718)
21. Karim SM, Rhee AY, Given AM, Faulx MD, Hoit BD, Brozovich FV. Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ Res 95: 612-618, 2004. (Pubitemid 39274376)
22. Khatri JJ, Joyce KM, Brozovich FV, Fisher SA. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001.
23. Kim D, Rybalkin SD, Pi XC, Wang Y, Zhang C, Münzel T, Beavo JA, Berk BC, Yan C. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 104: 2338-2343, 2001. (Pubitemid 33049518)
24. Lee CM, Kim BY, Li L, Morgan ET. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J Biol Chem 283: 889-898, 2008.
25. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8: 397-403, 1998.
26. Lee E, Hayes DB, Langsetmo K, Sundberg EJ, Tao TC. Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase. J Mol Biol 373: 1198-1212, 2007. (Pubitemid 47539483)
27. Lincoln TM, Dey N, Sellak H. cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91: 1421-1430, 2001. (Pubitemid 32803941)
28. Lu Y, Zhang H, Gokina N, Mandala M, Sato O, Ikebe M, Osol G, Fisher SA. Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy. Am J Physiol Cell Physiol 294: C564-C571, 2008.
29. MacPherson JD, Gillespie TD, Dunkerley HA, Maurice DH, Bennett BM. Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation. J Pharmacol Exp Ther 317: 188-195, 2006.
30. Matsumura F, Hartshorne DJ. Myosin phosphatase target subunit: many roles in cell function. Biochem Biophys Res Commun 369: 149-156, 2008.
31. Meyer RBJ, Miller JP. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci 14: 1019-1040, 1974.
32. Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25: 674-678, 1995.
33. Obrig TG, Culp WJ, McKeehan WL, Hardesty B. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J Biol Chem 246: 174-181, 1971.
34. Pagani ED, VanAller GS, O'Connor B, Silver PJ. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast. Eur J Pharmacol 243: 141-147, 1993.
35. Payne MC, Zhang HY, Prosdocimo T, Joyce KM, Koga Y, Ikebe M, Fisher SA. Myosin phosphatase isoform switching in vascular smooth muscle development. J Mol Cell Cardiol 40: 274-282, 2006.
36. Payne MC, Zhang HY, Shirasawa Y, Koga Y, Ikebe M, Benoit JN, Fisher SA. Dynamic changes in expression of myosin phosphatase in a model of portal hypertension. Am J Physiol Heart Circ Physiol 286: H1801-H1810, 2004.
37. Perkins WJ, Taniguchi M, Warner DO, Chini EN, Jones KA. Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide. Am J Physiol Lung Cell Mol Physiol 293: L84-L95, 2007. (Pubitemid 47080716)
38. Perkins WJ, Warner DO, Jones KA. Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity. Am J Physiol Lung Cell Mol Physiol 296: L121-L129, 2009.
39. Puetz S, Lubomirov LT, Pfitzer G. Regulation of smooth muscle contraction by small GTPases. Physiology (Bethesda) 24: 342-356, 2009.
40. Qi H, Zheng X, Qin X, Dou D, Xu H, Gao Y. Protein kinase G regulates the basal tension and plays a major role in nitrovasodilator-induced relaxation of porcine coronary veins. Br J Pharmacol 152: 1060-1069, 2007. (Pubitemid 350166051)
41. Qin X, Zheng X, Qi H, Dou D, Raj JU, Gao Y. cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery. Pflügers Arch 454: 913-923, 2007. (Pubitemid 47338456)
42. Schlossmann J, Desch M. cGK substrates. Handb Exp Pharmacol 191: 163-193, 2009.
43. Soff GA, Cornwell TL, Cundiff DL, Gately S, Lincoln TM. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100: 2580-2587, 1997. (Pubitemid 27514898)
44. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
45. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME. Regulation of Myosin Phosphatase by a Specific Interaction with cGMP- Dependent Protein Kinase I. Science 286: 1583-1587, 1999.
46. Twomey E, Li Y, Lei J, Sodja C, Ribecco-Lutkiewicz M, Smith B, Fang H, Bani-Yaghoub M, McKinnell I, Sikorska M. Regulation of MYPT1 stability by the E3 ubiquitin ligase SIAH2. Exp Cell Res 16: 68-77, 2010.
47. Wu X, Haystead TA, Nakamoto RK, Somlyo AV, Somlyo AP. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. J Biol Chem 273: 11362-11369, 1998.
48. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N, Hirata K, Akita H, Yokoyama M. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36: 97-102, 2000. (Pubitemid 30602159)
49. Zhang H, Fisher SA. Conditioning effect of blood flow on resistance artery smooth muscle myosin phosphatase. Circ Res 100: 730-737, 2007. (Pubitemid 46594888)